Center for Evolutionary Cognitive Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan.
Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan.
Epidemiol Psychiatr Sci. 2019 Nov 22;29:e74. doi: 10.1017/S2045796019000714.
Mental health-related stigma is a major challenge associated with the huge mental health treatment gap. It has remained unclear what kind of educational content is effective in reducing the stigma. Whether biomedical messages (BMM) about mental illness are effective or harmful in decreasing stigma is controversial. To investigate whether BMM can improve practically useful knowledge of mental illness, comparably to recommended messages (RCM) advocated by experts, of types such as 'recovery-oriented', 'social inclusion/human rights' and 'high prevalence of mental illnesses' through a randomised controlled trial (RCT).
This study is an individual-level RCT with a parallel-group design over 1 year, conducted in Tokyo, Japan. A total of 179 participants (males n = 80, mean age = 21.9 years and s.d. = 7.8) were recruited in high schools and universities, and through a commercial internet advertisement in June and July 2017, without any indication that the study appertained to mental health. Participants were allocated to the BMM and RCM groups. They underwent a 10-min intervention, and completed self-report questionnaires during baseline, post-test, 1-month follow-up and 1-year follow-up surveys. The primary outcome measures were practically useful knowledge of mental illness at the post-test survey using the Mental Illness and Disorder Understanding Scale (MIDUS). Analysis was conducted in October 2018.
Both groups demonstrated improved MIDUS score in the post-test survey, and showed similar intervention effects (F(1, 177) = 160.5, p < 0.001, η2 = 0.48). The effect of the interventions continued until the 1-year follow-up survey (B [95% CI] = -2.56 [-4.27, -0.85], p < 0.01), and showed no difference between groups. The reported adverse effect that BMM increase stigma was not confirmed.
BMM may have a positive impact on stigma, comparable to RCM. These findings may encourage reconsideration of the content of messages about mental health, as it is indicated that combining BMM and RCM might contribute to an effective anti-stigma programme.
心理健康相关的污名是与巨大的心理健康治疗差距相关的主要挑战。目前尚不清楚哪种教育内容在减少污名方面最有效。生物医学信息(BMM)对精神疾病是否有助于减少污名一直存在争议。本研究旨在通过一项随机对照试验(RCT),调查 BMM 是否可以通过提高对精神疾病的实用知识,与专家推荐的信息(RCM)相媲美,这些信息类型包括“以康复为导向”、“社会包容/人权”和“精神疾病高患病率”。
这是一项为期 1 年的个体水平 RCT,采用平行组设计,在日本东京进行。共有 179 名参与者(男性 n = 80,平均年龄 21.9 岁,标准差 = 7.8)在高中和大学招募,并通过 2017 年 6 月和 7 月的商业互联网广告招募,没有任何迹象表明该研究与心理健康有关。参与者被分配到 BMM 和 RCM 组。他们接受了 10 分钟的干预,在基线、后测、1 个月随访和 1 年随访调查中完成了自我报告问卷。主要的结局指标是后测调查中使用精神疾病和障碍理解量表(MIDUS)评估的对精神疾病的实用知识。分析于 2018 年 10 月进行。
两组在后测调查中 MIDUS 评分均有所提高,且干预效果相似(F(1, 177)= 160.5,p < 0.001,η2 = 0.48)。干预的效果持续到 1 年随访调查(B[95%CI]=-2.56[-4.27, -0.85],p < 0.01),且两组之间无差异。报道的 BMM 增加污名的不良影响未得到证实。
BMM 可能对减少污名产生积极影响,与 RCM 相当。这些发现可能鼓励重新考虑有关心理健康的信息内容,因为结合 BMM 和 RCM 可能有助于制定有效的反污名计划。